Can rivaroxaban be a drug of choice for treating heparin-induced thrombocytopenia in a patient with pulmonary thromboembolism?
作者信息
Vavlukis Marija, Kotlar Irina, Taravari Hajber, Poposka Lidija, Kedev Sasko
机构信息
University Clinic of Cardiology, Medical Faculty, University Ss' Cyril and Methodius; Skopje-Republic of Macedonia.
出版信息
Anatol J Cardiol. 2017 Jul;18(1):77-79. doi: 10.14744/AnatolJCardiol.2017.7805.
Abstract
摘要
Zotero 插件